Prostate Cancer
📧 Sign up to get email alerts when something new happens for Prostate Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: High Dose Rate (HDR) Brachytherapy Salvage After Prostatectomy
This clinical trial evaluates high-dose-rate brachytherapy as salvage radiotherapy for local recurrence of prostate cancer after prostatecto…
-
CLINICAL_TRIALS trial_result · 2025-06-19Clinical Trial Update: Characterizing Fatigue Experienced by Cancer Patients Receiving Primary Treatment and Cancer Survivors
Clinical trial update from NINR describes characterizing fatigue in cancer patients during primary treatment and in cancer survivors; the st…
-
CLINICAL_TRIALS trial_result · 2025-06-18Clinical Trial Update: PROState Pathway Embedded Comparative Trial
The PROState Pathway Embedded Comparative Trial conducted by Imperial College London has completed and posted results on 2025-06-18.
-
CLINICAL_TRIALS trial_result · 2025-06-17Clinical Trial Update: Safety and Efficacy Trial of a Targeted PSMA Fluorescent Contrast Agent (DGPR1008) for Intraoperative Imaging of Prostate Cancer [Phase 2]
This update reports the completed Phase 2 safety and efficacy study of the PSMA-targeted fluorescent contrast agent DGPR1008 for intraoperat…
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: Docetaxel, Carboplatin, and Rucaparib Camsylate in Treating Patients With Metastatic Castration Resistant Prostate Cancer With Homologous Recombination DNA Repair Deficiency [Phase 2]
A Phase 2 trial evaluating a combination of docetaxel, carboplatin, and rucaparib camsylate in metastatic castration-resistant prostate canc…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-06-12Clinical Trial Update: A Study of [18]F-PSMA-1007 in Patients With Known or Suspected Metastatic Prostate Cancer [Phase 2]
A Phase 2 trial evaluating [18]F-PSMA-1007 in patients with known or suspected metastatic prostate cancer has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-06-11Clinical Trial Update: Trial of Curcumin to Prevent Progression of Low-risk Prostate Cancer Under Active Surveillance [Phase 3]
A Phase 3 clinical trial investigating whether curcumin can prevent progression of low-risk prostate cancer in men under active surveillance…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Pembrolizumab With Combination Chemotherapy in Treating Participants With Locally Advanced or Metastatic Small Cell/Neuroendocrine Cancers of Urothelium or Prostate [Phase 1]
Phase 1 trial evaluating pembrolizumab with chemotherapy for locally advanced or metastatic small cell and neuroendocrine cancers of the uro…
-
CLINICAL_TRIALS trial_result · 2025-06-10Clinical Trial Update: Study of Chitosan for Pharmacologic Manipulation of AGE Levels in Prostate Cancer Patients [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating chitosan to pharmacologically manipulate AGE levels in prostate cancer was terminated; results were post…
-
CLINICAL_TRIALS trial_result · 2025-06-08Clinical Trial Update: Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1) [Phase 1, Phase 2]
This Phase I/II trial of BN-Brachyury Vaccine, M7824, N-803, and Epacadostat in metastatic castration-resistant prostate cancer has complete…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Platelet Rich Plasma During Radical Prostatectomy [NA]
A Mayo Clinic trial evaluated using platelet-rich plasma during radical prostatectomy for prostate cancer; the study is completed and result…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Triptorelin and Radiation Therapy in Treating Patients Who Have Undergone Surgery for Intermediate-Risk Stage III or Stage IV Prostate Cancer [Phase 3]
Phase 3 trial evaluating triptorelin in combination with radiation therapy after surgery for intermediate-risk stage III or stage IV prostat…
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors [Phase 2]
This is a Phase II multicohort trial assessing sEphB4-HSA in combination with pembrolizumab for solid tumors; the study is currently active …
-
CLINICAL_TRIALS trial_result · 2025-06-05Clinical Trial Update: Effects of Music and Conversation in Prostate Biopsy [NA]
A clinical trial update indicates the study on the effects of music and conversation during prostate biopsy has completed.
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Study to Learn About Novel Hormonal Therapies (NHTs) for Metastatic Castration-sensitive Prostate Cancer (mCSPC) in People Who Were in the Armed Forces
Pfizer conducted a study of novel hormonal therapies for metastatic castration-sensitive prostate cancer that has completed, with results po…
-
CLINICAL_TRIALS trial_result · 2025-06-04Clinical Trial Update: A Multi-Center Trial of Androgen Suppression With Abiraterone Acetate, Leuprolide, PARP Inhibition and Stereotactic Body Radiotherapy in Prostate Cancer [Phase 1, Phase 2]
A multi-center Phase 1/2 trial is evaluating androgen suppression with abiraterone acetate and leuprolide plus a PARP inhibitor and stereota…
-
CLINICAL_TRIALS trial_result · 2025-06-03Clinical Trial Update: Ferumoxtran-10-enhanced MRI in Prostate Cancer Patients [Phase 3]
A Phase 3 trial evaluating Ferumoxtran-10–enhanced MRI in prostate cancer patients has been terminated.
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: Combining EPI-7386 With Enzalutamide and Androgen Deprivation Therapy for Metastatic Hormone-Sensitive Prostate Cancer [Phase 2]
A Phase 2 trial update reports completing the study investigating combining EPI-7386 with enzalutamide and androgen deprivation therapy in m…
-
CLINICAL_TRIALS trial_result · 2025-05-29Clinical Trial Update: High Resolution, 18F-PSMA PET-MRI Before Prostate Cancer HIFU or Radical Prostatectomy [Phase 2]
A Phase 2 clinical trial evaluating high-resolution 18F-PSMA PET-MRI imaging before prostate cancer treatment (HIFU or radical prostatectomy…
-
CLINICAL_TRIALS trial_result · 2025-05-25Clinical Trial Update: A Digital Therapeutic Solution for Cancer Patients [NA]
A completed clinical trial update for a digital therapeutic targeting cancer patients. The study covers prostate cancer, colorectal cancer, …
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: PET/MRI for the Staging of Newly Diagnosed Prostate Cancer [EARLY_Phase 1]
Phase 1 study evaluating PET/MRI for staging newly diagnosed prostate cancer is active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-23Clinical Trial Update: Comparing Pre-Anesthesia Evaluation Via Telemedicine Versus in Person for Surgical Patients at Moffitt Cancer Center
This completed study compares telemedicine versus in-person pre-anesthesia evaluation for surgical patients at H. Lee Moffitt Cancer Center,…
-
CLINICAL_TRIALS trial_result · 2025-05-22Clinical Trial Update: The Study Will Evaluate if Leuprolide Mesylate is Safe and Effective in the Treatment of Subjects With Advanced Prostate Carcinoma, When Administered as Two Injections Six Months Apart. [Phase 3]
Phase 3 trial update describing leuprolide mesylate given as two injections six months apart for advanced prostate cancer; study status is c…
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: 11C-YJH08 PET Imaging for Detection of Glucocorticoid Receptor Expression [Phase 1]
Phase 1 trial evaluating the PET imaging tracer 11C-YJH08 for detecting glucocorticoid receptor expression in prostate cancer; the study was…
-
CLINICAL_TRIALS trial_result · 2025-05-18Clinical Trial Update: Post-Prostatectomy Linac-Based Ultrahypofractionated Radiotherapy for Patients With Localized Prostate Cancer [NA]
This clinical trial update concerns post-prostatectomy linac-based ultrahypofractionated radiotherapy for localized prostate cancer. The stu…